The pothole vs the worn road

"My MRI shows a focal cartilage defect" — three words into that phrase, most patients hear "arthritis" and assume the worst. The two conditions are structurally different in a way that matters directly for treatment.

A focal cartilage defect is a discrete, localised lesion — a pothole — in an otherwise largely sound joint surface, with healthy cartilage still intact around its edges. Osteoarthritis is the opposite: diffuse, global wear across the entire joint surface, with no healthy zone remaining. That structural difference is the hinge on which every treatment decision turns. The healthy cartilage borders encircling a focal defect are the biological anchor that repair and regeneration techniques depend upon; without intact borders, there is nothing to build against and nothing to hold a repair in place. Diffuse OA has no such borders — which is precisely why the surgical tools designed for focal defects do not work for osteoarthritis, and why joint replacement eventually becomes the only option in that setting.

Articular cartilage contains no blood vessels, so it cannot repair itself the way muscle or bone can. An untreated focal defect redistributes load onto the rim of healthy cartilage around it; that sustained mechanical stress can cause the lesion to enlarge over time and may, in some cases, progress toward the diffuse wear pattern of osteoarthritis.

The practical implication is one of direction. A focal finding on MRI is not an arthritis diagnosis — but it does warrant attention and, usually, action. It also opens a window of repair and regeneration options that diffuse OA closes. The sections below map what those options are and what determines which is appropriate.

How focal hip cartilage damage happens

Most people picture cartilage damage as something that accumulates slowly over decades. For a focal hip defect, the reality is often a single structural culprit — and many patients are in their 30s or 40s when the problem is first identified.

The most common cause in younger and active adults is femoroacetabular impingement (FAI). In a normal hip, the ball and socket move freely; in FAI, a small bony prominence — on the femoral head (cam type) or on the rim of the socket (pincer type) — catches against the acetabular cartilage during movement. The hip's ball-and-socket geometry concentrates this contact at a predictable zone, typically the anterosuperior surface of the acetabulum, producing a discrete lesion. Acute trauma, a sports impact, or the sequelae of a labral tear can generate the same kind of localised damage through different means.

Primary osteoarthritis develops along an entirely different path: gradual, systemic, age-related wear distributed across the whole joint surface. Because a focal defect has a specific mechanical cause rather than generalised degeneration, the surrounding cartilage tends to remain viable. That aetiological distinction has a practical consequence: correcting the underlying cause — for example, addressing the bony morphology responsible for FAI — is often incorporated into the overall treatment plan rather than treated as a separate matter.

What your MRI findings and grading score actually mean

An MRI report tends to arrive with a grade number and a clinical description — dense language that can feel alarming depending on which words catch the eye. Neither panic nor relief is usually the right response.

The ICRS (International Cartilage Repair Society) grading system runs from Grade 1 to Grade 4. Grades 1 and 2 describe surface-level softening or fissuring — the cartilage is damaged but substantially present. Grades 3 and 4 indicate deeper loss: Grade 3 lesions extend more than halfway through the cartilage thickness and are subclassified 3A through 3D according to depth, while Grade 4 represents a full breach through to the subchondral bone. The second key variable is surface area. Small defects under 2 cm², moderate lesions in the 2–3 cm² range, and larger defects at 3 cm² or more each map to a different set of repair and regeneration options — size is as important as grade when the consultant is choosing a technique.

Two points are worth understanding before reading too much into the numbers. First, a Grade 3 or 4 finding is not automatically a pathway to joint replacement; the consultant will look at the whole joint, not just the grade in isolation. Second, structural findings and symptoms do not always run in parallel. A significant chondral lesion on MRI can coexist with manageable pain, while a smaller defect in a mechanically sensitive area may produce disproportionate discomfort. Imaging is one tool the specialist brings to the assessment — not a verdict delivered in isolation.

Plain X-rays miss partial-thickness focal defects and can misrepresent the degree of joint space narrowing. In the hip specifically — where the ball-and-socket geometry and the labrum add layers of anatomical complexity — MRI is the only reliable way to characterise lesion depth, extent, and surrounding tissue quality.

Conservative management — what comes first

For most focal cartilage lesions that are not causing acute mechanical failure — locking, giving way, or severe swelling — structured conservative care is the appropriate starting point rather than immediate intervention.

Physiotherapy sits at the centre of this phase. A targeted programme addressing hip abductor and deep rotator strengthening, load management, and movement re-education reduces the stress that concentrates on the defect during daily activity. Done consistently, it protects the joint in a way that pain relief alone cannot.

NSAIDs and simple analgesics manage the inflammatory burden that amplifies symptoms but do not alter the cartilage lesion itself. Corticosteroid and hyaluronic acid injections can settle pain and stiffness sufficiently for physiotherapy to take effect — both are useful adjuncts at this stage, but neither regenerates tissue. Patients are better served by understanding clearly what each option is and is not doing.

Conservative care is honest about its limits. Symptom control and defect progression are separate matters, and in many cases the underlying lesion continues to evolve even when pain is manageable. If a structured programme over eight to twelve weeks has not produced meaningful improvement, that symptom trajectory — rather than scan appearance in isolation — is the appropriate trigger for specialist review.

Repair and regeneration options — what the evidence supports

Technique selection follows two numbers: lesion grade and surface area in cm². Together they determine what is biologically and mechanically feasible at each stage of the decision tree.

Microfracture (marrow stimulation) creates small channels through the subchondral bone so that mesenchymal stem cells can migrate into the defect and form repair tissue. It is most appropriate for smaller lesions under roughly 2–4 cm². The limitation is the tissue type it produces: fibrocartilage, which is mechanically inferior to native hyaline cartilage. Clinical scores in published series tend to decline over time, particularly at the upper end of that size range.

Mosaicplasty (OATS) transfers cylindrical osteochondral plugs from low-load regions of the same joint into the defect, delivering hyaline-like tissue. For small, well-contained lesions it is more durable than microfracture, but the technique carries donor-site morbidity — the gain in one area comes at a direct cost to another part of the joint, and size limits apply.

MACI (matrix-assisted autologous chondrocyte implantation) is the most evidence-supported option for defects of 3 cm² or more. The SUMMIT trial demonstrated superior KOOS pain and function scores at 2 and 5 years versus microfracture at this size threshold. Most trial data come from knee cohorts applied by extension to the hip; hip-specific evidence remains thinner, and a surgeon will factor that into their recommendation.

ChondroFiller injectable collagen scaffold is delivered as an ultrasound-guided outpatient injection, where it gels in situ and supports matrix-induced chondrogenesis — the patient's own progenitor cells migrate into the scaffold to form new tissue. More than 19,000 procedures have been performed across multiple joints globally; as with the surgical techniques above, the published evidence base is most established in the knee, and hip-specific trial data are limited.

CartiHeal Agili-C is a surgical biphasic implant designed for larger focal lesions — up to 7 cm² in Grade ≥3A joints. Its pivotal trial required Kellgren–Lawrence grade 0–3, excluding patients with significant diffuse disease, and the implant carries the recovery demands and eligibility restrictions of an operative procedure. It occupies a different niche from the non-surgical options above and is not appropriate for OA that has moved beyond the focal-defect window.

When joint replacement becomes the right answer — and how to get assessed

Total hip arthroplasty becomes the right pathway when biology — not preference — drives that conclusion: diffuse end-stage disease, uncorrected malalignment, ligamentous instability, or an inability to complete the rehabilitation that every repair technique demands. When those features are present, the entire repair and regeneration menu closes. For correctly selected patients, joint replacement is a reliable endpoint that restores function and quality of life — it is not a failure of the preceding pathway, simply the point at which a different tool becomes the appropriate one.

What the decision tree makes clear is that timing matters. A focal defect is not a stable finding; left unaddressed, it can expand as surrounding cartilage degenerates under abnormal load, and the options available to a patient narrow as the damage spreads. Seeking specialist review while healthy borders remain intact keeps more of the pathway open.

Assessment at a dedicated cartilage service goes beyond a standard orthopaedic opinion. It combines clinical history, imaging review, and a frank conversation about which techniques are anatomically and biologically feasible in that specific hip — not a generic consultation, but a technique-specific one. In the UK, the London Cartilage Clinic on Harley Street offers that assessment, including the ChondroFiller injectable collagen scaffold pathway for suitable focal defects, led by Professor Paul Lee. Appointments and further information are available at londoncartilage.com.

1. [1] Osteoarthritis. https://en.wikipedia.org/?curid=504841 https://en.wikipedia.org/?curid=504841
2. [2] Articular cartilage damage. https://en.wikipedia.org/?curid=19057920 https://en.wikipedia.org/?curid=19057920
3. [3] Femoroacetabular impingement. https://en.wikipedia.org/?curid=20754811 https://en.wikipedia.org/?curid=20754811
4. [4] Hyaline cartilage. https://en.wikipedia.org/?curid=1130627 https://en.wikipedia.org/?curid=1130627